Search Results - "Erhardt, L"

Recent Research on Team and Organizational Diversity: SWOT Analysis and Implications by Jackson, Susan E., Joshi, Aparna, Erhardt, Niclas L.

“…Sixty-three studies published in the years 1997–2002 are reviewed to assess the effects of workplace diversity on teams and organizations. Four major questions…”
Get full text

Board of Director Diversity and Firm Financial Performance by Erhardt, Niclas L., Werbel, James D., Shrader, Charles B.

“…This study examines the relationship between demographic diversity on boards of directors with firm financial performance. This relationship is examined using…”
Get full text

Cost effective management programme for heart failure reduces hospitalisation by Cline, C M J, Israelsson, B Y A, Willenheimer, R B, Broms, K, Erhardt, L R

“…Objective To study the effects of a management programme on hospitalisation and health care costs one year after admission for heart failure. Design…”
Get full text

Task force on the management of chest pain by Erhardt, L., Herlitz, J., Bossaert, L., Halinen, M., Keltai, M., Koster, R., Marcassa, C., Quinn, T., van Weert, H.

“…The Task Force on the management of chest pain was created by the committee for Scientific and Clinical Initiatives on 28 June 1997 after formal approval by…”
Get full text

Managing cardiovascular risk: the need for change by Volpe, M, Erhardt, L R W, Williams, B

Get full text

Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations : Main results of the GUARDIAN trial by THEROUX, P, CHAITMAN, B. R, DANCHIN, N, ERHARDT, L, MEINERTZ, T, SCHROEDER, J. S, TOGNONI, G, WHITE, H. D, WILLERSON, J. T, JESSEL, A

“…Background —The transmembrane sodium/hydrogen exchanger maintains myocardial cell pH integrity during myocardial ischemia but paradoxically may precipitate…”
Get full text

A global survey of physicians' perceptions on cholesterol management: the From The Heart study by Erhardt, L R, Hobbs, F D R

“…Guidelines for cardiovascular disease (CVD) prevention cite high levels of low-density lipoprotein cholesterol (LDL-C) as a major risk factor and recommend…”
Get more information

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice by McMurray, John, Cohen-Solal, Alain, Dietz, Rainer, Eichhorn, Eric, Erhardt, Leif, Hobbs, F.D. Richard, Krum, Henry, Maggioni, Aldo, McKelvie, Robert S., Piña, Ileana L., Soler-Soler, Jordi, Swedberg, Karl

“…Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of…”
Get full text

Left ventricular atrioventricular plane displacement: an echocardiographic technique for rapid assessment of prognosis in heart failure by Willenheimer, R., Cline, C., Erhardt, L., Israelsson, B.

“…OBJECTIVE: To assess the prognostic value of atrioventricular plane displacement in heart failure patients. DESIGN: Patients were followed prospectively for…”
Get full text

Non-compliance and knowledge of prescribed medication in elderly patients with heart failure by Cline, C.M.J., Björck-Linné, A.K., Israelsson, B.Y.A., Willenheimer, R.B., Erhardt, L.R.

“…Aims: To determine the extent of non‐compliance to prescribed medication in elderly patients with heart failure and to determine to what extent patients recall…”
Get full text

A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET) by Cleland, John G F, Charlesworth, Andrew, Lubsen, Jacobus, Swedberg, Karl, Remme, Willem J, Erhardt, Leif, Di Lenarda, Andrea, Komajda, Michel, Metra, Marco, Torp-Pedersen, Christian, Poole-Wilson, Philip A

“…This study was designed to investigate the loss of well-being, in terms of life-years, overall and in patients randomized to metoprolol versus carvedilol in…”
Get full text

A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile by Benner, J S, Erhardt, L, Flammer, M, Moller, R A, Rajicic, N, Changela, K, Yunis, C, Cherry, S B, Gaciong, Z, Johnson, E S, Sturkenboom, M C J M, García-Puig, J, Girerd, X

“…We assessed whether a novel programme to evaluate/communicate predicted coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk…”
Get more information

Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure by Tasevska-Dinevska, G, Kennedy, L.M, Cline-Iwarson, A, Cline, C, Erhardt, L, Willenheimer, R

“…Abstract Aim and methods We assessed gender differences in variables related to B-natriuretic peptide (BNP), left ventricular ejection fraction (LVEF), peak…”
Get full text

Exercise training in heart failure improves quality of life and exercise capacity by Willenheimer, R., Erhardt, L., Cline, C., Rydberg, E., Israelsson, B.

“…Aims Benefit from exercise training in heart failure has mainly been shown in men with ischaemic disease. We aimed to examine the effects of exercise training…”
Get full text

President's Introduction to the 2017 SESPRS Supplement by Erhardt, Walter L

Get full text

AT1-receptor blockers in hypertension and heart failure: clinical experience and future directions by Willenheimer, R., Dahlöf, B., Rydberg, E., Erhardt, L.

Get full text

A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure by Erhardt, L R

“…Angiotensin-converting enzyme (ACE) inhibitors have a central role in the management of heart failure, reflecting the contribution of the…”
Get more information

Providing high education for the European Cardiologist. A challenge for the future by Erhardt, L

Get full text

Recommendations for exercise testing in chronic heart failure patients

Get full text

Mode of death in chronic heart failure : A request and proposition for more accurate classification by NARANG, R, CLELAND, J. G. F, ERHARDT, L, BALL, S. G, COATS, A. J. S, COWLEY, A. J, DARGIE, H. J, HALL, A. S, HAMPTON, J. R, POOLE-WILSON, P. A

“…The proportion of patients reported to die suddenly or from progressive circulatory failure is not consistent among studies of heart failure. Lack of an…”
Get full text